Member Info for Heppi1234

back up to 65p now

whoever said 50-60% drop was about bang on the money :(

can currently buy at 0.567, been like that past couple of hours. glad I didn't take my advisory broker up on the 0.599 offer

hey all, new to this board, had multiple calls of my advisory broker today and finally got back to him before dinner after finished morning meetings. they are selling off the placement shares at 0.599, in lots of 200k or more, with much interest. so for those of you wondering where all the 0.599 sales are coming from today.....there's your answer. just reading up on the company and prospects now before giving him a decision on my position. if anyone has any insights they feel would be appropriate for a newcomer to the company please feel free to share. from what I've read so far certainly seems like some potential here. will be back once I've dug a little deeper atb

Notification of Major Interest in Shares Thu, 30th Mar 2017 17:10 RNS Number : 0834B Fusionex International PLC 30 March 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Fusionex International PLC 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights YES An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments An event changing the breakdown of voting rights Other (please specify): 3. Full name of person(s) subject to the notification obligation: Standard Life Investments (Holdings) Limited (Parent Company) 4. Full name of shareholder(s) (if different from 3.): 5. Date of the transaction and date on which the threshold is crossed or reached: 28/03/2017 6. Date on which issuer notified: 29/03/2017 7. Threshold(s) that is/are crossed or reached: Standard Life Investments (Holdings) Limited - 5% Standard Life Investments Limited - Below 5%

Fusionex, a leading provider of Analytics and Big Data software, is pleased to announce that it has won a major contract with Galaxy Entertainment Group, one of Asia's leading developers and operators of integrated entertainment and resort facilities. The initiative will include deployments of the upgraded GIANT 2017 platform to the hotel partners of the new client, which include Ritz-Carlton, Okura, Banyan Tree and JW Marriott. This multi-year deal will consolidate the client's facilities onto one engine and platform. Via this initiative, travellers will be able to make additional reservations for every lodging, entertainment, food & beverage, and travel facility available under the client's integrated resort umbrella. GIANT 2017 will track customer behavioural patterns and offer data-driven insights to enhance the client's offering. As the key driver for this initiative, the Fusionex Big Data Analytics (BDA) component gives the client the ability to record, analyse, and make sense of all its data, from customer demographics, purchasing habits, seasonal booking trends and others. Fusionex's GIANT 2017 is able to consolidate huge volumes of data at near real-time speeds, from a vast variety of different formats. It then cleanses, arranges and interprets the data in order to reveal trends, patterns and insights that a client can then use to determine better matches between products and customers, for highly targeted marketing campaigns and to streamline business processes for maximum efficiency.

Yes until standard life sell off their remaining shares ready for their merger it will keep the levels down a bit. shouldn't take long after to flourish though. a nice big win on the contract front again today. Edgasket are you not getting bored yet? we're all extremely bored of you

Fusionex, a leading provider of Analytics and Big Data software, is pleased to announce that it has won a new contract with a major multinational Asian healthcare company for GIANT 2017, its award-winning Big Data platform. The initial contract with the medical supplier is in the region of USD300,000, with the value expected to increase alongside the adoption rate within the client's various departments and at different offices across Asia. GIANT 2017 will enable the client to gain intelligent e-commerce insights to boost revenues and improve overall system management by the medical professionals across the business through a wide spectrum of data analytics. GIANT 2017 enables administrators to monitor user preferences and needs, as well as identify the preferences of medical professionals whether in terms of equipment, events or reading materials. The integrated regional medical supplier of equipment, supplies, and services supports a network of thousands of healthcare institutions, including government and private hospitals, surgery centers, specialist and primary care clinics, laboratories, and nursing homes across Asia.

Fusionex, a leading provider of Analytics and Big Data software, is pleased to announce that, ahead of the official launch of its significantly upgraded Big Data platform, GIANT 2017, the Group has won a five year, multi-million dollar contract with an Asian-based insurance company for the next generation solution. The new GIANT 2017 platform, which is targeted to be launched within this quarter, will not only accumulate and cleanse disparate external datasets for the client but also be used to find historical patterns and predict future trends in all types of data, including structured, semi-structured and unstructured information. Further information about the new platform will be issued at the time of the official launch. Following a competitive tender process, Fusionex will provide the client with a cost utilisation analytics module which will help to inform corporate customers about the performance of their accounts. Thanks to the upgraded functions of GIANT 2017, the technology will also help the customer formulate strategies to penetrate the insurance market through social media analytics and digital marketing.

So it was standard life that are the big seller. Not surprised with what they have going on currently. Should hopefully see some upward movement once their sell-off has cleared.

Mm's always love playing games. I'm happy to top up further at this price. Unfortunately due to meetings I only caught it at 137. Peel hunt have reiterated their buy rating for fxi with a price target of GBX 220, meaning upside potential of around 40-45%

Ed seriously if you have nothing to back your statements up please stop talking drivel. Just because you've been stung before doesn't mean every foreign company on lse is the same. For those with a vested interest in the company the full report is out today

Pi's being put off by edgasket really shouldn't be pi's imho

Very nice reading again today, as with last years results, push back above £2 would be nice

Fusionex, not Fusionthomas, autocorrect is a bugger

Ed sharing concerns on a company is all well and good.....saying a company is a scam because 'you've been burnt before' is not acceptable. If you had a better reputation (like some insightful conversations and posts on boards over a period of time) people may actually listen to you, but you don't, so as has previously been said you just look like a shorter trying to rattle inexperienced PI's

Fusionthomas don't post a financial calendar, so dates given on sites are normally always estimates. Last results were extremely positive and nothing looks to have changed this time around. The recent drop is unfortunate, but I'm expecting to see £2 again soon when RNS is released.

also this ed guys seems to be a really active and valuable contbuter to this site. member for 6+ years, first comment on another share in 2015, then 7 other comments here back end of 2016 basically saying the company is a scam......lets hope he doesnt return to this board

im contemplating pulling my funds out of sepura now it certainly seems a done (albeit it cheap) del with hytera, and throwing all into here ahead of news. wish this comany would get a little more exposure. 2017 could, and hopefully will be, a very big year for fusionex

Well it surpassed the 2 mark quicker than expected, this has definitely seemed to silence some of the doubters. Onwards and upwards here, glad I've been topping up on the lows. ATB